NA
IRWD icon

NewEdge Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

NewEdge Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.1K Buy
+2,392
New +$9.22K ﹤0.01% 3535
2026
Q1 		– Sell
-5,793
Closed -$19.5K – 4273
2025
Q4 		$19.5K Buy
+5,793
New +$15K ﹤0.01% 3268

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

NewEdge Advisors's IRWD Position: Q2 2026 in Review

NewEdge Advisors opened a new position in Ironwood Pharmaceuticals (IRWD) in Q2 2026: 2,392 shares worth $10.1K. The stake represents ﹤0.01% of the portfolio and ranks #3535 among its holdings. This is a return to the name: NewEdge Advisors previously reported a position in IRWD as recently as Q4 2025.

NewEdge Advisors first reported a position in IRWD in Q4 2025 and has held it in 2 quarters since. The position peaked at $19.5K in Q4 2025. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • NewEdge Advisors held 2,392 shares of Ironwood Pharmaceuticals worth $10.1K as of Q2 2026.
  • Ironwood Pharmaceuticals was a new NewEdge Advisors position in Q2 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #3535 holding.
  • NewEdge Advisors first reported a position in Ironwood Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • NewEdge Advisors's Ironwood Pharmaceuticals position peaked at $19.5K in Q4 2025.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.